Preclinical Studies Reverse Alzheimer’s Deficits by Targeting Cholesterol Uptake and Lithium Levels

Researchers are urging controlled clinical trials to establish safety, dosing and effectiveness following mouse studies that reversed Alzheimer’s pathology